Mathai Mammen, M.D., Ph.D.Founder

United States - Boston, Massachusetts

Mathai's life's mission is to build and inspire world-class teams to improve human health globally through creation of and access to advanced medicines and preventative treatments.

A highly experienced and mission-oriented biopharmaceutical executive who has built and grown a number of significant successful businesses, with a consistent record for over 25 years of creation of many transformational life-changing medicines. A trusted leader and partner to boards of directors, investors and CEOs as a holistic builder of businesses, solver of important problems and builder of best-in-class teams. Founded a company in his late 20s (Theravance) based on own ideas generated at Harvard University, created truly exceptional teams, five globally marketed products, and a pipeline of additional potential medicines. With management, spun off a royalty business Innoviva from Theravance. At Merck, evolved the research teams across Oncology, Immunology, Immuno-oncology and Cardiometabolic therapeutic areas with numerous products moved into the clinic. At J&J, fully transformed one of the largest R&D engines in the world to launch numerous important medicines, create one of the best pipelines in the industry and help drive growth of Janssen and J&J. Central to this successful growth was the coupling of data science with medical science and bold revisiting of any aspect of the business that would benefit. Place great value on creativity, focused risk-taking, urgency, and strong sense of execution, all with the patient at the center. By inspiring a culture of innovation, diligent risk-taking, and mutual respect, created a sense of belongingness and inclusiveness among team members, bringing out the very best of every team. And always thrilled to help bright entrepreneurs and young leaders shape a better world.